Location
Moultrie, GA
Start Date
17-4-2026 12:00 PM
End Date
17-4-2026 1:00 PM
Description
Introduction
Benign prostatic hyperplasia (BPH) is a highly prevalent condition among aging men and a major cause of lower urinary tract symptoms (LUTS). While BPH is extensively studied, inflammatory conditions of adjacent structures, particularly seminal vesiculitis, remain underrecognized. Undiagnosed seminal vesiculitis in patients with BPH may contribute to persistent urogenital symptoms, recurrent infections, fertility impairment, and post-procedural complications. The overlapping symptoms and shared inflammatory pathways between these conditions complicate diagnosis and management. This review evaluates the clinical implications of coexisting BPH and undiagnosed seminal vesiculitis.
Methods
A narrative review of the literature was conducted focusing on studies addressing BPH, seminal vesiculitis, chronic prostatitis, and their corresponding outcomes and complications. A Google Scholar search was conducted for articles published between 2000 and 2024 using the terms “benign prostatic hyperplasia” OR “chronic prostatitis” AND “seminal vesiculitis”. Articles addressing the clinical overlap between BPH and seminal vesiculitis, inflammatory mechanisms, infectious complications, fertility outcomes, or post-procedural effects were considered. Emphasis was placed on identifying overlapping clinical features, shared inflammatory mechanisms, reproductive implications, infectious sequelae, and gaps in current evidence.
Results
The literature demonstrates substantial clinical overlap between BPH and seminal vesiculitis. LUTS classically attributed to bladder outlet obstruction may coexist with or mask symptoms of seminal vesiculitis, including perineal pain, hematospermia, and ejaculatory discomfort. Chronic inflammation, characterized by elevated pro-inflammatory cytokines such as TNF-α and IL-6, appears central to both conditions and may amplify symptom severity.
Undiagnosed seminal vesiculitis may predispose patients with BPH to ascending genitourinary infections due to urinary stasis and impaired seminal vesicle drainage, contributing to recurrent prostatitis, epididymitis, and urinary tract infections. Fertility implications are also significant; inflammatory prostato-vesiculitis is associated with semen hyperviscosity, increased reactive oxygen species, altered seminal plasma composition, and downregulation of semenogelin I expression, all of which negatively affect sperm motility, viability, and DNA integrity.
Post-procedural complications following transurethral resection of the prostate (TURP) may be exacerbated by underlying seminal vesicle inflammation, including seminal vesicle urinary reflux, recurrent infection, pelvic pain, and delayed recovery. However, standardized diagnostic criteria for seminal vesiculitis remain lacking, epidemiologic data on its coexistence with BPH are sparse, and prospective interventional studies are limited.
Discussion
The coexistence of BPH and undiagnosed seminal vesiculitis has important clinical implications. Symptom overlap may delay accurate diagnosis, while persistent inflammation may sustain pelvic discomfort, infection risk, and reproductive dysfunction despite appropriate management of prostatic obstruction. Current literature is limited by the lack of standardized diagnostic criteria for seminal vesiculitis, insufficient mechanistic studies explaining how prostatic and seminal vesicle inflammation influence one another, and a shortage of prospective trials evaluating targeted treatment strategies. As a result, evidence-based guidance for screening and management remains limited. Greater clinical awareness, along with thorough evaluation using symptom assessment, laboratory testing, and appropriate imaging, is essential to improve diagnostic accuracy and optimize patient outcomes. Further research is needed to clarify pathophysiologic mechanisms and develop evidence-based screening and management strategies for patients with overlapping pathology to determine the root cause for effective treatment.
Embargo Period
5-28-2026
Included in
Implications of Benign Prostatic Hyperplasia and Undiagnosed Seminal Vesiculitis: A Literature Review
Moultrie, GA
Introduction
Benign prostatic hyperplasia (BPH) is a highly prevalent condition among aging men and a major cause of lower urinary tract symptoms (LUTS). While BPH is extensively studied, inflammatory conditions of adjacent structures, particularly seminal vesiculitis, remain underrecognized. Undiagnosed seminal vesiculitis in patients with BPH may contribute to persistent urogenital symptoms, recurrent infections, fertility impairment, and post-procedural complications. The overlapping symptoms and shared inflammatory pathways between these conditions complicate diagnosis and management. This review evaluates the clinical implications of coexisting BPH and undiagnosed seminal vesiculitis.
Methods
A narrative review of the literature was conducted focusing on studies addressing BPH, seminal vesiculitis, chronic prostatitis, and their corresponding outcomes and complications. A Google Scholar search was conducted for articles published between 2000 and 2024 using the terms “benign prostatic hyperplasia” OR “chronic prostatitis” AND “seminal vesiculitis”. Articles addressing the clinical overlap between BPH and seminal vesiculitis, inflammatory mechanisms, infectious complications, fertility outcomes, or post-procedural effects were considered. Emphasis was placed on identifying overlapping clinical features, shared inflammatory mechanisms, reproductive implications, infectious sequelae, and gaps in current evidence.
Results
The literature demonstrates substantial clinical overlap between BPH and seminal vesiculitis. LUTS classically attributed to bladder outlet obstruction may coexist with or mask symptoms of seminal vesiculitis, including perineal pain, hematospermia, and ejaculatory discomfort. Chronic inflammation, characterized by elevated pro-inflammatory cytokines such as TNF-α and IL-6, appears central to both conditions and may amplify symptom severity.
Undiagnosed seminal vesiculitis may predispose patients with BPH to ascending genitourinary infections due to urinary stasis and impaired seminal vesicle drainage, contributing to recurrent prostatitis, epididymitis, and urinary tract infections. Fertility implications are also significant; inflammatory prostato-vesiculitis is associated with semen hyperviscosity, increased reactive oxygen species, altered seminal plasma composition, and downregulation of semenogelin I expression, all of which negatively affect sperm motility, viability, and DNA integrity.
Post-procedural complications following transurethral resection of the prostate (TURP) may be exacerbated by underlying seminal vesicle inflammation, including seminal vesicle urinary reflux, recurrent infection, pelvic pain, and delayed recovery. However, standardized diagnostic criteria for seminal vesiculitis remain lacking, epidemiologic data on its coexistence with BPH are sparse, and prospective interventional studies are limited.
Discussion
The coexistence of BPH and undiagnosed seminal vesiculitis has important clinical implications. Symptom overlap may delay accurate diagnosis, while persistent inflammation may sustain pelvic discomfort, infection risk, and reproductive dysfunction despite appropriate management of prostatic obstruction. Current literature is limited by the lack of standardized diagnostic criteria for seminal vesiculitis, insufficient mechanistic studies explaining how prostatic and seminal vesicle inflammation influence one another, and a shortage of prospective trials evaluating targeted treatment strategies. As a result, evidence-based guidance for screening and management remains limited. Greater clinical awareness, along with thorough evaluation using symptom assessment, laboratory testing, and appropriate imaging, is essential to improve diagnostic accuracy and optimize patient outcomes. Further research is needed to clarify pathophysiologic mechanisms and develop evidence-based screening and management strategies for patients with overlapping pathology to determine the root cause for effective treatment.